Leo Sungwong Choi

5PUBLICATIONS
10CO-AUTHORS
Field organic and low chemical input horticultureMolecular targetsProteins and peptidesGlycoconjugatesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 09, 2024
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis.

Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim

|Jan 22, 2024
Vutiglabridin Alleviates Cellular Senescence with Metabolic Regulation and Circadian Clock in Human Dermal Fibroblasts.

Jin-Woong Heo, Hye-Eun Lee, Jimin Lee

|May 16, 2023
Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice.

Dawoud Sulaiman, Leo Sungwong Choi, Hyeong Min Lee

|Mar 11, 2023
Synthetic Glabridin Derivatives Inhibit LPS-Induced Inflammation via MAPKs and NF-κB Pathways in RAW264.7 Macrophages.

Jaejin Shin, Leo Sungwong Choi, Hyun Ju Jeon

|Sep 18, 2020
Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesity.

Leo Sungwong Choi, In Geun Jo, Ku Suk Kang

Pageof 1

Frequent Collaborators

3 joint publications

Jaejin Shin

1 joint publications

Hyeong Min Lee

1 joint publications

Pierre Eftekhari

1 joint publications

Srinivasa T Reddy